| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |